KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other Non-Current Liabilities: 2017-2025

Historic Other Non-Current Liabilities for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to $281.0 million.

  • Moderna's Other Non-Current Liabilities rose 1.81% to $281.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $281.0 million, marking a year-over-year increase of 1.81%. This contributed to the annual value of $267.0 million for FY2024, which is 4.30% up from last year.
  • Latest data reveals that Moderna reported Other Non-Current Liabilities of $281.0 million as of Q3 2025, which was up 1.81% from $276.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Other Non-Current Liabilities peaked at $281.0 million during Q3 2025, and registered a low of $1.0 million during Q2 2021.
  • In the last 3 years, Moderna's Other Non-Current Liabilities had a median value of $266.0 million in 2024 and averaged $242.4 million.
  • In the last 5 years, Moderna's Other Non-Current Liabilities crashed by 54.19% in 2021 and then spiked by 11,200.00% in 2022.
  • Over the past 5 years, Moderna's Other Non-Current Liabilities (Quarterly) stood at $76.0 million in 2021, then spiked by 77.63% to $135.0 million in 2022, then skyrocketed by 89.63% to $256.0 million in 2023, then climbed by 4.30% to $267.0 million in 2024, then grew by 1.81% to $281.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $281.0 million for Q3 2025, versus $276.0 million for Q2 2025 and $274.0 million for Q1 2025.